| Literature DB >> 36216414 |
Hong Zhang1, Min Wang2, Yun Zhang2, Ping Cen3, Chuanyi Ning4,5, Sumin Tan2, Haimei Huang2, Jiawen Zhu6, Weiyi Tian2, Jinli Mo6, Jieling Mo2.
Abstract
INTRODUCTION: HIV self-testing (HIVST) provides a key measure for the early detection of HIV infection in men who have sex with men (MSM). However, dual HIV/syphilis self-testing in the MSM population has not been studied. We describe a randomised controlled trial to evaluate the effect of dual HIV/syphilis self-testing on the testing frequency among MSM in China. METHODS AND ANALYSIS: This randomised controlled trial will be implemented in Guangxi, China. 330 MSM, including 255 frequent testers and 75 less frequent testers, will be recruited and randomly assigned in a 1:1:1 ratio into one of three arms: a site-based testing arm, a single HIVST arm and a dual HIV/syphilis self-testing arm. Participants in the single HIVST arm and dual HIV/syphilis self-testing arm will receive two free finger-prick-based HIVST or HIV/syphilis self-testing kits at enrolment. The data will be collected at five separate times: baseline, 3 months, 6 months, 9 months and 12 months. The primary outcome is the mean frequency of HIV testing used by MSM after intervention comparing each group during the study period. The secondary outcome includes changes in sex behaviours (eg, number of male sex partners and the proportion of consistent condom use) and the mean number of HIV tests used by the social network members over the study period. ETHICS AND DISSEMINATION: The study protocol was reviewed and approved by the Medical Ethics Committee of Guangxi Medical University, China (20210173). The study results will be disseminated through conferences and academic journals. TRIAL REGISTRATION NUMBER: ChiCTR2100050898. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: Clinical trials; HIV & AIDS; Protocols & guidelines
Mesh:
Year: 2022 PMID: 36216414 PMCID: PMC9558798 DOI: 10.1136/bmjopen-2021-059034
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Figure 1Study design. MSM, men who have sex with men.
Figure 2Social network distribution. QR, quick response.
Figure 3Uploading system of HIV testing results. OR, quick response.
Timeline of the study
| Study period | |||||||
| Time point | Enrolment | Allocation | Postallocation | Close-out | |||
| September 2021–February 2022 | September 2021–February 2022 | T1* | T2† | T3‡ | T4§ | March–August 2023 | |
| Enrolment: | |||||||
| Recruitment | × | ||||||
| Informed consent | × | ||||||
| Eligibility screen | × | ||||||
| Allocation | × | ||||||
| Interventions: | |||||||
| Single HIV self-testing | × | × | × | × | |||
| Dual HIV/syphilis self-testing | × | × | × | × | |||
| Site-based testing | × | × | × | × | |||
| Assessments | |||||||
| Baseline questionnaire | × | ||||||
| Follow-up questionnaire | × | × | × | × | |||
| Analyse data | × | ||||||
*T1: 1–3 months after enrolment.
†T2: 3–6 months after enrolment.
‡T3: 6–9 months after enrolment.
§T4: 9–12 months after enrolment.